Sklip Inc.
Detect skin cancer from anywhere in under 5 seconds using a Sklip FDA Class 1 dermatoscope with our proprietary Ai-driven software digital health platform.
- Stage Product In Market
- Industry Digital Health
- Location Lake Oswego, OR, USA
- Currency USD
- Founded October 2020
- Employees 11
- Incorporation Type C-corp
- Website sklip.ai
Company Summary
Sklip is a software-based digital health platform app that incorporates our subscription-based, proprietary Ai-driven software with FDA Breakthrough Designation Status. Our patent pending hardware smartphone attachment lets any user take FDA Class 1 medical grade images of a concerning skin lesion (mole). TAM is 58 million American skin cancer survivors and over 2 million medical professionals in the United States and Europe.
Team
-
CEO / Co-FounderDr. Witkowski founded Sklip Inc. and developed the FDA Class 1 smartphone dermatoscope with proprietary Ai that received FDA Breakthrough Designation Status. He is internationally recognized for his expertise in early skin cancer detection and was voted Chair of the American Academy of Dermatology Cutaneous Imaging Expert Resource Group in 2023, the highest leadership position for skin cancer triage and diagnostics in the United States.
Advisors
-
Alex Anne Brown PA-C - Board certified national dermoscopy expertUnconfirmed -
Marcia Walsh - Melanoma survivor patient advocateUnconfirmed
Previous Investors
-
Michael Speight PhD - Business scaling consultantUnconfirmed
Roger Dailey MD, FACSUnconfirmed -
Timothy TaborUnconfirmed
Linda DillardUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.